Abstract
Poloxamers (PL) are copolymers A-B-A type consisting of ethylene oxide (EO) and propylene oxide (PO) units in a triblock EOx–POy–EOx arrangement. These copolymers are interesting due to their ability for temperature-dependent gel formation, as a result of their self-assembling in micelles. Several studies have demonstrated the application of the thermoreversible copolymers as drug-delivery systems in order to prolong the drug release, to sustain the effectiveness, and also to reduce local and/or systemic toxicity, connecting the expertise of different research fields such as Biochemistry, Nanotechnology, Biopharmaceutics, Pharmacology, and Toxicology. Then, the purpose of this chapter involves a discussion about PL copolymers in the light of those research fields.
The development of one-type or binary PL carriers systems is a function of composition (type of copolymer, differences on EO/PO units number, molecular weight), physicochemical properties (hydrophilic-lipophilic balance, cloud point, critical micellar concentration), and structural parameters such as micellar size, temperature for micelles, and hydrogels assembling. Besides, for focusing on how PL can be useful to achieve sustained drug release it is necessary to consider their pharmacological properties (such as the ability to inhibit the P-glycoprotein), in vitro (cytotoxicity or cytoprotection and their mechanisms) and in vivo toxicological evaluation (biocompatibility and regulatory aspects).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abe T, Sasaki M, Nakajima H et al (1990) Evaluation of Pluronic F127 as a base for gradual release of anticancer drug. Gan To Kagaku Ryoho 17:1546–1550
Alakhova DY, Rapoport NY, Batrakova EV et al (2010) Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers. J Control Release 142:89–100
Alexandridis P (1994) Surface activity of poly(ethylene oxide)-block-poly(propylene oxide)-block-poly(ethylene oxide) copolymers. Langmuir 10:2604–2612
Alexandridis P, Hatton AT (1995) Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling. Colloid Surf A: Physicochem Eng Aspects 96:1–46
Alvarez-Lorenzo C, Sosnik A, Concheiro A (2011) PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy. Curr Drug Targets 12:1112–1130
Arora A, Seth K, Kalra N et al (2005) Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol. Toxicol Appl Pharmacol 202:237–243
Artzner F, Geiger S, Olivier A et al (2007) Interactions between poloxamers in aqueous solutions: micellization and gelation studied by differential scanning calorimetry, small angle X-ray scattering, and rheology. Langmuir 23:5085–5092
Balayssac D, Authier N, Cayre A et al (2005) Does inhibition of P-glycoprotein lead to drug-drug interactions? Toxicol Lett 156:319–329
Batrakova EV, Kabanov AV (2008) Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 130:98–106
Batrakova EV, Li S, Brynskikh AM et al (2010) Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Control Release 143:290–301
Blonder JM, Baird L, Fulfs JC, Rosenthal GJ (1999) Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel. Life Sci 65:261–266
Campese GM, Rodrigues EMG, Tambourgi EB et al (2003) Determination of cloud-point temperatures for different copolymers. Braz J Chem Eng 20:335–337
Chaibundit C, Ricardo NMPS, Costa FLL et al (2007) Effect of ethanol on the micellization and gelation of pluronic P123. Langmuir 23:9229–9236
Cheng C, Wang J, Kausik R et al (2012) Nature of interactions between PEO-PPO-PEO triblock copolymers and lipid membranes: (II) role of hydration dynamics revealed by dynamic nuclear polarization. Biomacromolecules 13:2624–2633
Chieng YY, Chen SB (2009) Interaction and complexation of phospholipid vesicles and triblock copolymers. J Phys Chem 113:14934–14942
Croy SR, Kwon GS (2006) Polymeric micelles for drug delivery. Curr Pharm Des 12:4669–4684
Demina T, Grozdova I, Krylova O et al (2005) Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers. Biochemistry 44:4042–4054
Dumortier G, Grossiord JL, Agnely F et al (2006) A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23:2709–2728
Escobar-Chávez JJ, López-Cervantes M, Naïk A et al (2006) Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 9:339–358
Fu D, Arias IM (2012) Intracellular trafficking of P-glycoprotein. Int J Biochem Cell Biol 44:461–464
Fusco S, Borzacchiello A, Netti PA (2006) Perspectives on: PEO-PPO-PEO triblock copolymers and their biomedical applications. J Bioact Compat Polym 21:149–164
Gaspar R, Ducan R (2009) Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics. Adv Drug Deliv Rev 61:1220–1231
Gaumet M, Vargas A, Gurny R et al (2008) Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 69:1–9
Gong J, Chen M, Zheng Y et al (2012) Polymeric micelles drug delivery system in oncology. J Control Release 159:312–323
Greenebaum B, Blossfield K, Hannig J et al (2004) Poloxamer 188 prevents acute necrosis of adult skeletal muscle cells following high-dose irradiation. Burns 30:539–547
Guzmán M, García FF, Molpeceres J et al (1992) Polyoxyethylene-polyoxypropylene block copolymer gels as sustained release vehicles for subcutaneous drug administration. Int J Pharm 80:119–127
Han M, Diao Y, Jiang H et al (2011) Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle. Int J Pharm 420:404–411
Harrison WJ, Aboulgassem GJ, Elathrem FAI et al (2005) Regression of poloxamer 407-induced atherosclerotic lesions in C57BL/6 mice using atorvastatin. Langmuir 21:6170–6178
Higuchi A, Aoki N, Yamamoto T et al (2006) Bioinert surface of pluronic-immobilized flask for preservation of hematopoietic stem cells. Biomacromolecules 7:1083–1089
Hu H, Yu J, Li Y et al (2012) Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. J Biomed Mater Res A 100:141–188
Hvidt S, Trandum C, Batsberg W (2002) Effects of poloxamer polydispersity on micellization in water. J Colloid Interface Sci 250:243–250
Ieiri I (2012) Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2) (2012). Drug Metab Pharmacokinet 27:85–105
Ivanova R, Lindman B, Alexandridis P (2002) Effect of pharmaceutically acceptable glycols on the stability of the liquid crystalline gels formed by poloxamer 407 in water. J Colloid Interface Sci 252:226–235
Jiang J, Li C, Lombardi C et al (2008) The effect of physiologically relevant additives on the rheological properties of concentrated Pluronic copolymer gels. Polymer 49:3561–3567
Johnston TP, Miller SC (1985) Toxicological evaluation of poloxamer vehicles for intra-muscular use. J Parenter Sci Technol 39:83–88
Johnston TP, Miller SC (1989) Inulin disposition following intramuscular administration of an inulin/poloxamer gel matrix. J Parenter Sci Technol 43:279–286
Johnston TP, Baker JC, Hall D et al (2000) Regression of poloxamer 407-induced atherosclerosis lesions in C57BL/6 mice using atorvastatin. Atherosclerosis 149:303–314
Kabanov AV, Batrakova EV, Alakhov VY (2002a) Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev 54:759–779
Kabanov A, Batrakova E, Alakhov VY (2002b) Pluronic® copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 82:189–212
Kabanov AV, Batrakova EV, Alakhov VY (2003) An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. J Control Release 91:75–83
Kadam Y, Yerramilli U, Bahadur A et al (2010) Micelles from PEO-PPO-PEO block copolymers as nanocontainers for solubilization of a poorly water soluble drug hydrochlorothiazide. Colloids Surf B Biointerfaces 83:49–57
Kidowaki M, Zhao C, Kataoka T et al (2006) Thermoreversible sol–gel transition of an aqueous solution of polyrotaxane composed of highly methylated α-cyclodextrin and polyethylene glycol. Chem Commun (Camb) 39:4102–4103
Klouda L, Mikos AG (2008) Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. Eur J Pharm Biopharm 68:34–45
Kozlov MY, Melik-Nubarov NS, Batrakova E et al (2000) Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes. Macromolecules 33:3305–3313
Li C, Palmer WK, Johnston TP (1996) Disposition of poloxamer 407 in rats following a single intraperitoneal injection assessed using a simplified colorimetric assay. J Pharm Biomed Anal 14:659–666
Li X, Li P, Zhang Y et al (2010) Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously. Pharm Res 27:1498–1511
Liu T, Chu B (2000) Formation of homogeneous gel-like phases by mixed triblock copolymer micelles in aqueous solution: FCC to BCC phase transition. J Appl Cryst 33:727–730
Luo C, Chen X, Li Q et al (2013) Poloxamer 188 attenuates in vitro traumatic brain injury-induced mitochondrial and lysosomal membrane permeabilization damage in cultured primary neurons. J Neurotrauma 30(7):597–607. doi:10.1089/neu.2012.2425
Mata JP, Majhi PR, Guo C et al (2005) Concentration, temperature, and salt-induced micellization of a triblock copolymer Pluronic L64 in aqueous media. J Colloid Interface Sci 292:548–556
McDevit CA, Callaghan R (2007) How can we best use structural information on P-glycoprotein to design inhibitors? Pharmacol Ther 113:429–441
Minko T, Batrakova EV, Li S et al (2005) Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells. J Control Release 105:269–278
Mitchard NM, Beezer AE, Mitchell JC et al (1992) Thermodynamic analysis of scanning calorimetric transitions observed for dilute aqueous solutions of ABA block copolymers. J Phys Chem 96:9507–9512
Montesinos RN, Béduneau A, Pellequer Y et al (2012) Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes. J Control Release 161:50–61
Mora-Huertas C, Fessi H, Elaissari A (2010) Polymer-based nanocapsules for drug delivery. Int J Pharm 385:113–142
Mortensen K, Batsberg W, Hvidt S (2008) Effects of PEO-PPO diblock impurities on the cubic structure of aqueous PEO-PPO-PEO pluronics micelles: fcc and bcc ordered structures in F127. Macromolecules 41:1720–1727
Nagarajan R (1999) Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic® (PEO–PPO–PEO) block copolymers. Colloids Surf B Biointerfaces 16:55–72
Nambam J, Philip J (2012) Effects of interaction of ionic and nonionic surfactants on self-assembly of PEO–PPO–PEO triblock copolymer in aqueous solution. J Phys Chem B 116:1499–1507
Newby GE, Hamley IW, King SM et al (2009) Structure, rheology and shear alignment of Pluronic block copolymer mixtures. J Colloid Interface Sci 329:54–61
Oh KT, Bronich TK, Kabanov AV (2004) Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic® block copolymers. J Control Release 94:411–422
Overstreet DJ, Huynh R, Jarbo K et al (2013) In situ forming, resorbable graft copolymer hydrogels providing controlled drug release. J Biomed Mater Res A 101(5):1437–1446. doi:10.1002/jbm.a.34443
Pandit NK, Wang D (1998) Salt effects on the diffusion and release rate of propranolol from poloxamer 407 gels. Int J Pharm 167:183–189
Parmar A, Singh K, Bahadur A et al (2011) Interaction and solubilization of some phenolic antioxidants in Pluronic® micelles. Colloids Surf B Biointerfaces 86:319–326
Pec EA, Wout ZG, Johnston TP (1992) Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat. J Pharm Sci 81:626–630
Quadir A (2005) Characterization of newly developed micronized poloxamers for poorly soluble drugs. Basf Pharma Solutions, Miami
Schmolka IR (1972) Artificial skin I. Preparation and properties of pluronic F‐127 gels for treatment of burns. J Biomed Mater Res 6:571–582
Sharma PK, Reilly MJ, Bhatia SK et al (2008) Effect of pharmaceuticals on thermoreversible gelation of PEO-PPO-PEO copolymers. Colloids Surf B Biointerfaces 63:229–235
Shen J, Yin Q, Chen L et al (2012) Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer. Biomaterials 33:8613–8624
Singh-Joy SD, McLain VC (2008) Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics. Int J Toxicol 27:93–128
Su Y, Wang J, Liu H (2002) Melt, hydration, and micellization of the PEO–PPO–PEO block copolymer studied by FTIR spectroscopy. J Colloid Interface Sci 251:417–423
Vadnere M, Amidon G, Lindebaum S et al (1984) Thermodynamic studies on the gel-sol transition of some pluronic polyols. Int J Pharm 22:207–218
Wang J, Chin J, Marks JD et al (2010) Effects of PEO-PPO-PEO triblock copolymers on phospholipid membrane integrity under osmotic stress. Langmuir 26:12953–12961
Weinand C, Pomerantseva I, Neville C et al (2006) Hydrogel-beta-TCP scaffolds and stem cells for tissue engineering bone. Bone 38:555–563
Wu C, Liu T, Chu B (1997) Characterization of the PEO-PPO-PEO triblock copolymer and its application as a separation medium in capillary electrophoresis. Macromolecules 30:4574–4583
Yapar EA, Inal O (2012) Poly(ethylene oxide)–poly(propylene oxide)-based copolymers for transdermal drug delivery: an overview. Trop J Pharmaceut Res 11:855–866
Yuhua S, Ligen L, Jiake C et al (2012) Effect of Poloxamer 188 on deepening of deep second-degree burn wounds in the early stage. Burns 38:95–101
Zhang Y, Lam YM (2006) Study of mixed micelles and interaction parameters for polymeric nonionic and normal surfactants. J Nanosci Nanotechnol 6:3877–3881
Zhang Y, Lam Y, Tan W (2005) Poly(ethylene oxide)–poly(propylene oxide)–poly(ethylene oxide)-g-poly (vinylpyrrolidone): association behavior in aqueous solution and interaction with anionic surfactants. J Colloid Interface Sci 285:74–79
Zhao L, Du J, Duan Y et al (2012) Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf B Biointerfaces 97:101–108
Zhirnov AE, Demina TV, Krylova OO et al (2005) Lipid composition determines interaction of liposome membranes with Pluronic L61. Biochim Biophys Acta 1720:73–83
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
de Araújo, D.R., Oshiro, A., da Silva, D.C., Akkari, A.C.S., de Mello, J.C., Rodrigues, T. (2014). Poloxamers as Drug-Delivery Systems: Physicochemical, Pharmaceutical, and Toxicological Aspects. In: Durán, N., Guterres, S., Alves, O. (eds) Nanotoxicology. Nanomedicine and Nanotoxicology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8993-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8993-1_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8992-4
Online ISBN: 978-1-4614-8993-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)